Subscribe free to our newsletters via your
  Medical and Hospital News  




Subscribe free to our newsletters via your




















INTERN DAILY
Bioinspired agent kills drug-resistant bacteria
by Staff Writers
Washington DC (SPX) May 04, 2017


An antimicrobial treatment, inspired by enzymes in our immune system, can rapidly kill drug-resistant bacteria. Credit: Lilit Tonoyan, National University of Ireland Galway, Ireland

Researchers in Ireland have developed a bioinspired antimicrobial treatment that can rapidly kill drug-resistant bacteria. The treatment consists of iodo-thiocyanate complexes, which are inspired by enzymes and reactive molecules produced by our immune system.

Microbial resistance to antibiotics and biocides is increasing, and our ability to effectively treat bacterial infections and contamination is under threat. It is important that scientists develop new antibiotic drugs, but we also need new strategies to deal with bacterial contamination that are not reliant on antibiotics.

"The rise of 'superbugs' leaves the clinical community with a rapidly dwindling number of options to treat infectious disease and to prevent the spread of resistant bacteria in, for example, hospital settings," explains Professor Vincent O'Flaherty of the National University of Ireland Galway, co-corresponding author on the study, recently published in Frontiers in Microbiology.

Hospital-acquired infections are a major concern for elderly or infirm patients. When the infection is antibiotic-resistant, serious illness or death can result. Bacterial contamination can occur on medical devices, such as catheters, which are embedded in patients.

Bacteria tend to aggregate on these implants and form slimy layers called biofilms, and biofilms can also form on chronic wounds, impairing wound-healing. Biofilms are particularly resistant to decontamination strategies.

With this in mind, the researchers set out to develop an effective antibacterial treatment, drawing their inspiration from naturally-occurring peroxidase enzymes that play a role in immune defence against bacterial infections.

Peroxidases can produce highly reactive oxidized molecules in the presence of hydrogen peroxide. Naturally present in bodily secretions such as saliva, milk and tears, these highly reactive substances can cause damage to bacterial cells, resulting in their death.

However, enzymes are expensive and impractical to produce in the quantities required for a widely useable antibacterial treatment. So, the researchers came up with an enzyme-free system consisting of hydrogen peroxide and two oxidizable substances, iodide and thiocynate. These iodo-thiocyanate complexes produce highly reactive anti-microbial substances, without a peroxidase enzyme.

The team tested the complexes' ability to kill a variety of bacterial strains, including MRSA, an antibiotic-resistant strain. To do this, they treated the bacteria in cell suspensions, where the bacterial cells float freely, or in biofilms. They also tested if the bacteria became resistant to the complexes, by incubating them with small doses over time.

The complexes caused rapid bacterial death in all the tested strains, in some instances killing the bacteria within 30 seconds, even in small doses. They could kill both free-floating bacteria and those in biofilms, suggesting that they could be used for decontamination in a variety of situations. Finally, the complexes were also effective against MRSA, and the tested bacteria did not develop resistance over time.

Antibiotics often work by targeting one specific site in a bacterium. By including two oxidizable substances, the complexes produce a cocktail of antimicrobial molecules, damaging multiple bacterial sites simultaneously. This means that bacteria are unlikely to develop resistance to the complexes.

The team hope that the complexes could be applied as a disinfectant or even used to directly treat infected wounds. "We will need to assess the safety and suitability of the complexes for use in, or on, humans," says O'Flaherty.

"We also need to develop delivery systems to deploy the treatment in a variety of settings that are currently affected by antibiotic-resistant bacteria."

The list of potential applications includes pre-surgery skin washes, disinfection of hospital surfaces and instruments, wound care, treatment of ulcers, and decontamination of medical devices.

Research paper

INTERN DAILY
Fungi have enormous potential for new antibiotics
Gothenburg, Germany (SPX) Apr 24, 2017
Fungi are a potential goldmine for the production of pharmaceuticals. This is shown by researchers at Chalmers University of Technology, who have developed a method for finding new antibiotics from nature's own resources. The findings - which could prove very useful in the battle against antibiotic resistance - were recently published in the journal, Nature Microbiology. Antibiotics have s ... read more

Related Links
Frontiers
Hospital and Medical News at InternDaily.com

Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.

SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only

Comment using your Disqus, Facebook, Google or Twitter login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

INTERN DAILY
US opioid crisis at epidemic proportions

Bullying is on the decline in most schools, new research shows

When bridges collapse; Are we underestimating the risks

Cities provide paths from poverty to sustainability

INTERN DAILY
2 SOPS says goodbye to GPS satellite

Researchers working toward indoor location detection

Galileo's search and rescue service in the spotlight

Russia inaugurates GPS-type satellite station in Nicaragua

INTERN DAILY
Brazil's indigenous leader Raoni: youths losing their culture

Population growth, spread responsible for human advancement

Early evidence of Middle Stone Age projectiles found in South Africa's Sibudu Cave

Bonobos may be better representation of last common ancestor with humans

INTERN DAILY
Invasive Asian clam makes its North American debut

Scientists suggest the world should brace itself for a new wave of biological invasions

Scientists uncover substance telling ants which will become queens

Scientists find new population of endangered cats in Borneo

INTERN DAILY
Suspected meningitis epidemic kills 745 in Nigeria

Diarrhoea kills more than 500 in Somalia since January: UN

A big-picture look at the world's worst Ebola epidemic

Viral fossils reveal how our ancestors may have eliminated an ancient infection

INTERN DAILY
12 dead in tunnel blast in southwest China

Hong Kong remembers bloodiest violence 50 years on

Opera troupe tours rural China defending a dying art

World's only Tiananmen museum returns to Hong Kong

INTERN DAILY
Indian, Chinese navies rescue ship hijacked by Somali pirates

Philippines seeks US, China help to combat sea pirates

INTERN DAILY



Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News






The content herein, unless otherwise known to be public domain, are Copyright 1995-2017 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement